Positive CHMP Vote for Pemigatinib for the Treatment of Adults with pre-treated, locally advanced or metastatic Cholangiocarcinoma with Fusion or Rearrangement of Fibroblast Growth Factor Receptor 2-MedSci.cn

Positive CHMP Vote for Pemigatinib for the Treatment of Adults with pre-treated, locally advanced or metastatic Cholangiocarcinoma with Fusion or Rearrangement of Fibroblast Growth Factor Receptor 2

[Anonymous]

ONCOLOGY RESEARCH AND TREATMENT, 2021; 44 (3):

科室
- - 订阅+
  - 更多科室
工具
服务